Program areas at FtB
Free To Breathe community events, including run/walks, bike rides and yogathons were organized throughout the nation To raise awareness of and research dollars for lung cancer. In 2017, the Free To Breathe series took place in more than 40 locations and included a national walk, making it the largest branded national lung cancer event series. More than 10,000 people were involved in the events.
Free To Breathe creates and distributes Free print and online educational materials on lung cancer causes, symptoms, prevention, treatments and clinical trials for patients, their caregivers and their medical teams. In 2017, approximately 40,000 individuals accessed these materials. In addition, over 50,000 individuals were emailed our newsletter with valuable information for the entire lung cancer community. Innumerable additional people have received critical information through electronic communications, social media and in-person events.
Free To Breathe organizes annual conferences To provide forums for internationally renowned clinical experts and community oncologists, nurses, pharmacists, patient advocates, and other healthcare professionals To discuss current and evolving therapies in the screening, diagnosis, and management of patients with lung cancer. Free To Breathe co-hosted the focus on lung cancer, patient and caregiver program conference with penn medicine abramson cancer center, with a focus on non-small cell and small cell lung cancer. This Free conference was designed for those at risk, newly diagnosed, currently in treatment or survivor on non-small cell and small cell lung cancer, family members, caregivers or healthcare professionals. The conference provided educational presentations regarding diagnosis, treatment, and coping with lung cancer, and information about advancements in research. The conference also provided materials for patients and caregivers.
Free To Breathe supports research in lung cancer. In 2017, grants were provided To 7 researchers To institutions across the united states. In addition, Free To Breathe administers the lung cancer mutation consortium, which is prospectively analyzing the genomic makeup of patient tumors and matching patients To appropriate clinical trials. Funds are provided To member institutions To offset the costs of tumor testing. Oversight is provided by an executive committee, including several of the top lung cancer researchers in the country.